Deal Announcement 07/25: Healthcare

The Deal

The PwC M&A team is pleased to announce that the private shareholders have successfully sold a majority stake in CRITEX GmbH (“CRITEX”) to NEXUS AG (“NEXUS”). CRITEX is a leading provider of specialized software solutions for the fertility healthcare sector and markets its software products under the brand name MedITEX. The management team will retain a minority stake in the company and continue to drive the growth and international expansion of CRITEX alongside NEXUS.

PwC M&A conducted a structured global sales process, with PwC Legal providing legal SPA services to the sellers.

The share purchase agreement was signed and closed in July 2025.

CRITEX GmbH

Founded in 2000 and headquartered in Regensburg, Germany, CRITEX is a leading provider of documentation and practice management software for the fertility healthcare sector. MedITEX is an all-in-one solution for IVF clinics and is used by over 450 facilities in more than 50 countries. Offering a wide range of add-ons, it is an open and customizable ecosystem tailored to the clinic’s needs, which is helping to digitalize and improve workflows for nurses, clinicians, embryologists, and management.

NEXUS AG

Headquartered in Donaueschingen, Germany, NEXUS is a leading provider of healthcare software solutions. The company develops and distributes modular software solutions for the international healthcare market, in particular for hospitals, psychiatric clinics, rehabilitation and diagnostic centers. Through the strategic acquisition of CRITEX, the company offers the market-leading solutions in women’s health & babies’ solutions.

PwC

The global PricewaterhouseCoopers network is a worldwide association of independent auditing and consulting companies which together employ more than 370,000 people in 149 countries. Our global network comprises over 2,900 M&A professionals all over the world, realising approx. 400 successful transactions per year. We specialise in a wide range of independent M&A services including advice on acquisitions and disposals, mergers, public takeovers, privatisations as well as structured financing.

PwC M&A Germany acted as exclusive financial advisor to the sellers in this transaction. The M&A deal team consisted of Alexander von Friesen (Partner), Hannes Stötefalke (Senior Manager), Ibrahim Günal (Senior Associate) and Maik Piel (Associate).

The PwC Legal Team consisted of Moritz Gröning (Partner, Legal Deals, lead), Jascha Fröhler, and Tomke Blendermann (both Senior Associate, Legal Deals), Susanne Zühlke (Partner, Regulatory), Thomas Urband (Senior Manager), Dinor Khadrijaj (Senior Associate, both IP/IT/Commercial).